Extracorporeal Membrane Oxygenation as Circulatory Support in Adult Patients with Septic Shock: A Systematic Review.

Pub Date : 2024-04-30 eCollection Date: 2024-04-01 DOI:10.2478/jccm-2024-0017
Muhammad Faisal Khan, Mohsin Nazir, Muhammad Khuzzaim Khan, Raj Kumar Rajendram, Faisal Shamim
{"title":"Extracorporeal Membrane Oxygenation as Circulatory Support in Adult Patients with Septic Shock: A Systematic Review.","authors":"Muhammad Faisal Khan, Mohsin Nazir, Muhammad Khuzzaim Khan, Raj Kumar Rajendram, Faisal Shamim","doi":"10.2478/jccm-2024-0017","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The utilization of extracorporeal membrane oxygenation (ECMO) in adult patients experiencing septic shock is a subject of ongoing debate within the medical community. This study aims to comprehensively address this issue through a systematic review conducted in accordance with the PRISMA guidelines.</p><p><strong>Aim of study: </strong>The primary objective of this study is to assess the outcomes of ECMO utilization in adult patients diagnosed with septic shock, thereby providing insights into the potential benefits and uncertainties associated with this treatment modality.</p><p><strong>Materials and methods: </strong>Our research encompassed a thorough search across electronic databases for relevant English-language articles published up until April 2023. The inclusion criteria were based on studies reporting on ECMO usage in adult patients with septic shock. Among the eligible studies meeting these criteria, a total of eleven were included in our analysis, involving a cohort of 512 patients. The mean age of the participants was 53.4 years, with 67.38% being male.</p><p><strong>Results: </strong>In the pooled analysis, the mean survival rate following ECMO treatment was found to vary significantly across different ECMO modalities. Patients receiving venovenous-ECMO (VV-ECMO) and veno-venous-arterial ECMO (VVA-ECMO) demonstrated higher survival rates (44.5% and 44.4%, respectively) compared to those receiving venoarterial-ECMO (VA-ECMO) at 25% (p<0.05). A chi-square test of independence indicated that the type of ECMO was a significant predictor of survival (χ<sup>2</sup>(2) = 6.63, p=0.036). Additionally, patients with septic shock stemming from respiratory failure demonstrated survival rates ranging from 39% to 70%. Predictors of mortality were identified as older age and the necessity for cardiopulmonary resuscitation (CPR).</p><p><strong>Conclusions: </strong>In septic shock patients, ECMO outcomes align with established indications like respiratory and cardiogenic shock. VV-ECMO and VVA-ECMO suggest better prognoses, though the optimal mode remains uncertain. Patient selection should weigh age and CPR need. Further research is vital to determine ECMO's best approach for this population.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193963/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/jccm-2024-0017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The utilization of extracorporeal membrane oxygenation (ECMO) in adult patients experiencing septic shock is a subject of ongoing debate within the medical community. This study aims to comprehensively address this issue through a systematic review conducted in accordance with the PRISMA guidelines.

Aim of study: The primary objective of this study is to assess the outcomes of ECMO utilization in adult patients diagnosed with septic shock, thereby providing insights into the potential benefits and uncertainties associated with this treatment modality.

Materials and methods: Our research encompassed a thorough search across electronic databases for relevant English-language articles published up until April 2023. The inclusion criteria were based on studies reporting on ECMO usage in adult patients with septic shock. Among the eligible studies meeting these criteria, a total of eleven were included in our analysis, involving a cohort of 512 patients. The mean age of the participants was 53.4 years, with 67.38% being male.

Results: In the pooled analysis, the mean survival rate following ECMO treatment was found to vary significantly across different ECMO modalities. Patients receiving venovenous-ECMO (VV-ECMO) and veno-venous-arterial ECMO (VVA-ECMO) demonstrated higher survival rates (44.5% and 44.4%, respectively) compared to those receiving venoarterial-ECMO (VA-ECMO) at 25% (p<0.05). A chi-square test of independence indicated that the type of ECMO was a significant predictor of survival (χ2(2) = 6.63, p=0.036). Additionally, patients with septic shock stemming from respiratory failure demonstrated survival rates ranging from 39% to 70%. Predictors of mortality were identified as older age and the necessity for cardiopulmonary resuscitation (CPR).

Conclusions: In septic shock patients, ECMO outcomes align with established indications like respiratory and cardiogenic shock. VV-ECMO and VVA-ECMO suggest better prognoses, though the optimal mode remains uncertain. Patient selection should weigh age and CPR need. Further research is vital to determine ECMO's best approach for this population.

分享
查看原文
体外膜氧合作为脓毒性休克成人患者的循环支持:系统综述。
导言:体外膜氧合(ECMO)在脓毒性休克成人患者中的应用一直是医学界争论不休的话题。本研究旨在通过按照 PRISMA 指南进行的系统性综述全面探讨这一问题:本研究的主要目的是评估被诊断为脓毒性休克的成人患者使用 ECMO 的结果,从而深入了解与这种治疗方式相关的潜在益处和不确定性:我们的研究包括在电子数据库中彻底搜索截至 2023 年 4 月发表的相关英文文章。纳入标准基于有关脓毒性休克成人患者使用 ECMO 的研究报告。在符合这些标准的研究中,共有 11 项纳入了我们的分析,涉及 512 名患者。参与者的平均年龄为 53.4 岁,67.38% 为男性:结果:在汇总分析中发现,不同 ECMO 模式的患者接受 ECMO 治疗后的平均存活率差异很大。接受静脉-ECMO(VV-ECMO)和静脉-静脉-动脉 ECMO(VVA-ECMO)治疗的患者存活率更高(分别为 44.5% 和 44.4%),而接受静脉-动脉-ECMO(VA-ECMO)治疗的患者存活率仅为 25% (p2(2) = 6.63, p=0.036)。此外,呼吸衰竭引起的脓毒性休克患者的存活率从39%到70%不等。结论:在脓毒性休克患者中,使用心肺复苏(CPR)是最有效的治疗方法:结论:在脓毒性休克患者中,ECMO 的结果与呼吸性休克和心源性休克等既定适应症一致。VV-ECMO和VVA-ECMO的预后较好,但最佳模式仍不确定。患者选择应权衡年龄和心肺复苏需求。进一步的研究对于确定 ECMO 在这一人群中的最佳应用至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信